sulfamethoxazole has been researched along with Blastomycosis, North American in 2 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Havas, L | 1 |
| Joseph, EA | 1 |
| Mare, A | 1 |
| Irving, WR | 1 |
2 other studies available for sulfamethoxazole and Blastomycosis, North American
| Article | Year |
|---|---|
[The treatment of various deep mycoses (South American blastomycosis, nocardiosis, actinomycetoma) with the drug combination sulfamethoxazole+trimethoprim (bactrim, septrin). Review of the literature].
Topics: Actinomycetales; Actinomycetales Infections; Blastomyces; Blastomycosis; Dapsone; Drug Combinations; | 1975 |
Oral South American blastomycosis in the United States of America. Report of a case.
Topics: Aged; Blastomycosis; Humans; Male; Sulfamethoxazole; Sulfonamides; Tooth Extraction; United States | 1966 |